INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2233034, encodeId=d13d2233034dd, content=INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES刚刚被科睿唯安（Clarivate Analytics）列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章，这意味着这些期刊的质量和学术诚信正在接受严格审查。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:56:27 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2228528, encodeId=f2d12228528f5, content=偏重的研究方向：药学 经验分享：这个杂志被ON HOLD了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9db08404890, createdName=ms9000001848883162, createdTime=Mon Sep 30 12:15:28 CST 2024, time=2024-09-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2222607, encodeId=4a2b222260e4f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿发邮件说接受了，但是网站上文章状态显示还是已提交修改怎么回事呀？等了快一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14e68366610, createdName=ms1000001977574257, createdTime=Tue Aug 27 09:03:57 CST 2024, time=2024-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220206, encodeId=841a222020637, content=见刊非常快，我是有这个编辑的邮箱，两周录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8857069, createdName=ms9000000801705910, createdTime=Thu Aug 15 10:02:57 CST 2024, time=2024-08-15, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2131249, encodeId=4121213124922, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：综合性期刊 经验分享：这个杂志非常安全，从未被预警过，本人发表了三篇，想咨询投稿后各个阶段状态和时间的可以咨询我，这个杂志的录用还是有些小窍门的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:42:12 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1196620, encodeId=4a841196620f8, content=您好，请教一下我每次提交文档都显示Invalid Captcha !!!，无法提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erqVLaq9Pf3WYPIXYjLw47yjVBxITzicTZ0q07rhKdyumOthJibQIJFdwKe3ibJ6K8TAFWfQT2YL4x2Q/132, createdBy=7cda2060778, createdName=earsmile, createdTime=Wed Feb 23 23:33:44 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122750, encodeId=16152122e507a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：色谱 经验分享：这个期刊带药物相关的，比较好录用，1个月能搞定，<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220712/73e5adb12e9542ba82e0cdedcb6f7d85/9147fd82fb334746850dda7ccd06a4c9.jpg, createdBy=fab48234685, createdName=小红帽起飞, createdTime=Thu Mar 30 15:04:38 CST 2023, time=2023-03-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214670, encodeId=3b1512146e0f9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉都没送出去审，半个月就给录用了，是增刊。需要付版面费，本来要2800欧，后来还价到1800欧，，，，相当水了，不过老板愿意付钱就好了，毕竟为了评奖学金不寒碜=-= , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=ms8000001934264310, createdTime=Tue Apr 26 18:14:17 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102586, encodeId=4b162102586f5, content=怎么回事，投稿几天后系统里面看不到自己的稿件状态了，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 25 12:29:10 CST 2022, time=2022-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2092855, encodeId=bdf4209285523, content=一直显示Invalid Captcha !!!，用过好多浏览器，都不行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71e38135633, createdName=ms6000000209127283, createdTime=Mon Oct 10 11:43:15 CST 2022, time=2022-10-10, status=1, ipAttribution=)]

2024-10-25 侠胆医心来自威斯康星

INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES刚刚被科睿唯安（Clarivate Analytics）列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章，这意味着这些期刊的质量和学术诚信正在接受严格审查。

15 0

[GetPortalCommentsPageByObjectIdResponse(id=2233034, encodeId=d13d2233034dd, content=INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES刚刚被科睿唯安（Clarivate Analytics）列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章，这意味着这些期刊的质量和学术诚信正在接受严格审查。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:56:27 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2228528, encodeId=f2d12228528f5, content=偏重的研究方向：药学 经验分享：这个杂志被ON HOLD了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9db08404890, createdName=ms9000001848883162, createdTime=Mon Sep 30 12:15:28 CST 2024, time=2024-09-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2222607, encodeId=4a2b222260e4f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿发邮件说接受了，但是网站上文章状态显示还是已提交修改怎么回事呀？等了快一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14e68366610, createdName=ms1000001977574257, createdTime=Tue Aug 27 09:03:57 CST 2024, time=2024-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220206, encodeId=841a222020637, content=见刊非常快，我是有这个编辑的邮箱，两周录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8857069, createdName=ms9000000801705910, createdTime=Thu Aug 15 10:02:57 CST 2024, time=2024-08-15, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2131249, encodeId=4121213124922, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：综合性期刊 经验分享：这个杂志非常安全，从未被预警过，本人发表了三篇，想咨询投稿后各个阶段状态和时间的可以咨询我，这个杂志的录用还是有些小窍门的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:42:12 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1196620, encodeId=4a841196620f8, content=您好，请教一下我每次提交文档都显示Invalid Captcha !!!，无法提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erqVLaq9Pf3WYPIXYjLw47yjVBxITzicTZ0q07rhKdyumOthJibQIJFdwKe3ibJ6K8TAFWfQT2YL4x2Q/132, createdBy=7cda2060778, createdName=earsmile, createdTime=Wed Feb 23 23:33:44 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122750, encodeId=16152122e507a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：色谱 经验分享：这个期刊带药物相关的，比较好录用，1个月能搞定，<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220712/73e5adb12e9542ba82e0cdedcb6f7d85/9147fd82fb334746850dda7ccd06a4c9.jpg, createdBy=fab48234685, createdName=小红帽起飞, createdTime=Thu Mar 30 15:04:38 CST 2023, time=2023-03-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214670, encodeId=3b1512146e0f9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉都没送出去审，半个月就给录用了，是增刊。需要付版面费，本来要2800欧，后来还价到1800欧，，，，相当水了，不过老板愿意付钱就好了，毕竟为了评奖学金不寒碜=-= , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=ms8000001934264310, createdTime=Tue Apr 26 18:14:17 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102586, encodeId=4b162102586f5, content=怎么回事，投稿几天后系统里面看不到自己的稿件状态了，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 25 12:29:10 CST 2022, time=2022-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2092855, encodeId=bdf4209285523, content=一直显示Invalid Captcha !!!，用过好多浏览器，都不行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71e38135633, createdName=ms6000000209127283, createdTime=Mon Oct 10 11:43:15 CST 2022, time=2022-10-10, status=1, ipAttribution=)]

2024-09-30 ms9000001848883162 来自江苏省

偏重的研究方向：药学
经验分享：这个杂志被ON HOLD了吗？

18 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233034, encodeId=d13d2233034dd, content=INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES刚刚被科睿唯安（Clarivate Analytics）列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章，这意味着这些期刊的质量和学术诚信正在接受严格审查。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:56:27 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2228528, encodeId=f2d12228528f5, content=偏重的研究方向：药学 经验分享：这个杂志被ON HOLD了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9db08404890, createdName=ms9000001848883162, createdTime=Mon Sep 30 12:15:28 CST 2024, time=2024-09-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2222607, encodeId=4a2b222260e4f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿发邮件说接受了，但是网站上文章状态显示还是已提交修改怎么回事呀？等了快一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14e68366610, createdName=ms1000001977574257, createdTime=Tue Aug 27 09:03:57 CST 2024, time=2024-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220206, encodeId=841a222020637, content=见刊非常快，我是有这个编辑的邮箱，两周录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8857069, createdName=ms9000000801705910, createdTime=Thu Aug 15 10:02:57 CST 2024, time=2024-08-15, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2131249, encodeId=4121213124922, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：综合性期刊 经验分享：这个杂志非常安全，从未被预警过，本人发表了三篇，想咨询投稿后各个阶段状态和时间的可以咨询我，这个杂志的录用还是有些小窍门的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:42:12 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1196620, encodeId=4a841196620f8, content=您好，请教一下我每次提交文档都显示Invalid Captcha !!!，无法提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erqVLaq9Pf3WYPIXYjLw47yjVBxITzicTZ0q07rhKdyumOthJibQIJFdwKe3ibJ6K8TAFWfQT2YL4x2Q/132, createdBy=7cda2060778, createdName=earsmile, createdTime=Wed Feb 23 23:33:44 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122750, encodeId=16152122e507a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：色谱 经验分享：这个期刊带药物相关的，比较好录用，1个月能搞定，<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220712/73e5adb12e9542ba82e0cdedcb6f7d85/9147fd82fb334746850dda7ccd06a4c9.jpg, createdBy=fab48234685, createdName=小红帽起飞, createdTime=Thu Mar 30 15:04:38 CST 2023, time=2023-03-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214670, encodeId=3b1512146e0f9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉都没送出去审，半个月就给录用了，是增刊。需要付版面费，本来要2800欧，后来还价到1800欧，，，，相当水了，不过老板愿意付钱就好了，毕竟为了评奖学金不寒碜=-= , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=ms8000001934264310, createdTime=Tue Apr 26 18:14:17 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102586, encodeId=4b162102586f5, content=怎么回事，投稿几天后系统里面看不到自己的稿件状态了，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 25 12:29:10 CST 2022, time=2022-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2092855, encodeId=bdf4209285523, content=一直显示Invalid Captcha !!!，用过好多浏览器，都不行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71e38135633, createdName=ms6000000209127283, createdTime=Mon Oct 10 11:43:15 CST 2022, time=2022-10-10, status=1, ipAttribution=)]

2024-08-27 ms1000001977574257 来自安徽省

审稿速度:1.0 | 投稿命中率:50.0
经验分享：投稿发邮件说接受了，但是网站上文章状态显示还是已提交修改怎么回事呀？等了快一周了

25 0

[GetPortalCommentsPageByObjectIdResponse(id=2233034, encodeId=d13d2233034dd, content=INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES刚刚被科睿唯安（Clarivate Analytics）列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章，这意味着这些期刊的质量和学术诚信正在接受严格审查。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:56:27 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2228528, encodeId=f2d12228528f5, content=偏重的研究方向：药学 经验分享：这个杂志被ON HOLD了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9db08404890, createdName=ms9000001848883162, createdTime=Mon Sep 30 12:15:28 CST 2024, time=2024-09-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2222607, encodeId=4a2b222260e4f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿发邮件说接受了，但是网站上文章状态显示还是已提交修改怎么回事呀？等了快一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14e68366610, createdName=ms1000001977574257, createdTime=Tue Aug 27 09:03:57 CST 2024, time=2024-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220206, encodeId=841a222020637, content=见刊非常快，我是有这个编辑的邮箱，两周录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8857069, createdName=ms9000000801705910, createdTime=Thu Aug 15 10:02:57 CST 2024, time=2024-08-15, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2131249, encodeId=4121213124922, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：综合性期刊 经验分享：这个杂志非常安全，从未被预警过，本人发表了三篇，想咨询投稿后各个阶段状态和时间的可以咨询我，这个杂志的录用还是有些小窍门的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:42:12 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1196620, encodeId=4a841196620f8, content=您好，请教一下我每次提交文档都显示Invalid Captcha !!!，无法提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erqVLaq9Pf3WYPIXYjLw47yjVBxITzicTZ0q07rhKdyumOthJibQIJFdwKe3ibJ6K8TAFWfQT2YL4x2Q/132, createdBy=7cda2060778, createdName=earsmile, createdTime=Wed Feb 23 23:33:44 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122750, encodeId=16152122e507a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：色谱 经验分享：这个期刊带药物相关的，比较好录用，1个月能搞定，<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220712/73e5adb12e9542ba82e0cdedcb6f7d85/9147fd82fb334746850dda7ccd06a4c9.jpg, createdBy=fab48234685, createdName=小红帽起飞, createdTime=Thu Mar 30 15:04:38 CST 2023, time=2023-03-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214670, encodeId=3b1512146e0f9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉都没送出去审，半个月就给录用了，是增刊。需要付版面费，本来要2800欧，后来还价到1800欧，，，，相当水了，不过老板愿意付钱就好了，毕竟为了评奖学金不寒碜=-= , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=ms8000001934264310, createdTime=Tue Apr 26 18:14:17 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102586, encodeId=4b162102586f5, content=怎么回事，投稿几天后系统里面看不到自己的稿件状态了，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 25 12:29:10 CST 2022, time=2022-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2092855, encodeId=bdf4209285523, content=一直显示Invalid Captcha !!!，用过好多浏览器，都不行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71e38135633, createdName=ms6000000209127283, createdTime=Mon Oct 10 11:43:15 CST 2022, time=2022-10-10, status=1, ipAttribution=)]

2024-08-15 ms9000000801705910 来自宁夏

见刊非常快，我是有这个编辑的邮箱，两周录用

44 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233034, encodeId=d13d2233034dd, content=INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES刚刚被科睿唯安（Clarivate Analytics）列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章，这意味着这些期刊的质量和学术诚信正在接受严格审查。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:56:27 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2228528, encodeId=f2d12228528f5, content=偏重的研究方向：药学 经验分享：这个杂志被ON HOLD了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9db08404890, createdName=ms9000001848883162, createdTime=Mon Sep 30 12:15:28 CST 2024, time=2024-09-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2222607, encodeId=4a2b222260e4f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿发邮件说接受了，但是网站上文章状态显示还是已提交修改怎么回事呀？等了快一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14e68366610, createdName=ms1000001977574257, createdTime=Tue Aug 27 09:03:57 CST 2024, time=2024-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220206, encodeId=841a222020637, content=见刊非常快，我是有这个编辑的邮箱，两周录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8857069, createdName=ms9000000801705910, createdTime=Thu Aug 15 10:02:57 CST 2024, time=2024-08-15, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2131249, encodeId=4121213124922, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：综合性期刊 经验分享：这个杂志非常安全，从未被预警过，本人发表了三篇，想咨询投稿后各个阶段状态和时间的可以咨询我，这个杂志的录用还是有些小窍门的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:42:12 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1196620, encodeId=4a841196620f8, content=您好，请教一下我每次提交文档都显示Invalid Captcha !!!，无法提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erqVLaq9Pf3WYPIXYjLw47yjVBxITzicTZ0q07rhKdyumOthJibQIJFdwKe3ibJ6K8TAFWfQT2YL4x2Q/132, createdBy=7cda2060778, createdName=earsmile, createdTime=Wed Feb 23 23:33:44 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122750, encodeId=16152122e507a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：色谱 经验分享：这个期刊带药物相关的，比较好录用，1个月能搞定，<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220712/73e5adb12e9542ba82e0cdedcb6f7d85/9147fd82fb334746850dda7ccd06a4c9.jpg, createdBy=fab48234685, createdName=小红帽起飞, createdTime=Thu Mar 30 15:04:38 CST 2023, time=2023-03-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214670, encodeId=3b1512146e0f9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉都没送出去审，半个月就给录用了，是增刊。需要付版面费，本来要2800欧，后来还价到1800欧，，，，相当水了，不过老板愿意付钱就好了，毕竟为了评奖学金不寒碜=-= , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=ms8000001934264310, createdTime=Tue Apr 26 18:14:17 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102586, encodeId=4b162102586f5, content=怎么回事，投稿几天后系统里面看不到自己的稿件状态了，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 25 12:29:10 CST 2022, time=2022-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2092855, encodeId=bdf4209285523, content=一直显示Invalid Captcha !!!，用过好多浏览器，都不行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71e38135633, createdName=ms6000000209127283, createdTime=Mon Oct 10 11:43:15 CST 2022, time=2022-10-10, status=1, ipAttribution=)]

2023-05-09 ms7000000507856696 来自江苏省

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：综合性期刊
经验分享：这个杂志非常安全，从未被预警过，本人发表了三篇，想咨询投稿后各个阶段状态和时间的可以咨询我，这个杂志的录用还是有些小窍门的。

0 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233034, encodeId=d13d2233034dd, content=INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES刚刚被科睿唯安（Clarivate Analytics）列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章，这意味着这些期刊的质量和学术诚信正在接受严格审查。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:56:27 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2228528, encodeId=f2d12228528f5, content=偏重的研究方向：药学 经验分享：这个杂志被ON HOLD了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9db08404890, createdName=ms9000001848883162, createdTime=Mon Sep 30 12:15:28 CST 2024, time=2024-09-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2222607, encodeId=4a2b222260e4f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿发邮件说接受了，但是网站上文章状态显示还是已提交修改怎么回事呀？等了快一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14e68366610, createdName=ms1000001977574257, createdTime=Tue Aug 27 09:03:57 CST 2024, time=2024-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220206, encodeId=841a222020637, content=见刊非常快，我是有这个编辑的邮箱，两周录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8857069, createdName=ms9000000801705910, createdTime=Thu Aug 15 10:02:57 CST 2024, time=2024-08-15, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2131249, encodeId=4121213124922, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：综合性期刊 经验分享：这个杂志非常安全，从未被预警过，本人发表了三篇，想咨询投稿后各个阶段状态和时间的可以咨询我，这个杂志的录用还是有些小窍门的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:42:12 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1196620, encodeId=4a841196620f8, content=您好，请教一下我每次提交文档都显示Invalid Captcha !!!，无法提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erqVLaq9Pf3WYPIXYjLw47yjVBxITzicTZ0q07rhKdyumOthJibQIJFdwKe3ibJ6K8TAFWfQT2YL4x2Q/132, createdBy=7cda2060778, createdName=earsmile, createdTime=Wed Feb 23 23:33:44 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122750, encodeId=16152122e507a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：色谱 经验分享：这个期刊带药物相关的，比较好录用，1个月能搞定，<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220712/73e5adb12e9542ba82e0cdedcb6f7d85/9147fd82fb334746850dda7ccd06a4c9.jpg, createdBy=fab48234685, createdName=小红帽起飞, createdTime=Thu Mar 30 15:04:38 CST 2023, time=2023-03-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214670, encodeId=3b1512146e0f9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉都没送出去审，半个月就给录用了，是增刊。需要付版面费，本来要2800欧，后来还价到1800欧，，，，相当水了，不过老板愿意付钱就好了，毕竟为了评奖学金不寒碜=-= , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=ms8000001934264310, createdTime=Tue Apr 26 18:14:17 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102586, encodeId=4b162102586f5, content=怎么回事，投稿几天后系统里面看不到自己的稿件状态了，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 25 12:29:10 CST 2022, time=2022-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2092855, encodeId=bdf4209285523, content=一直显示Invalid Captcha !!!，用过好多浏览器，都不行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71e38135633, createdName=ms6000000209127283, createdTime=Mon Oct 10 11:43:15 CST 2022, time=2022-10-10, status=1, ipAttribution=)]

2022-02-23 earsmile

您好，请教一下我每次提交文档都显示Invalid Captcha !!!，无法提交

78 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233034, encodeId=d13d2233034dd, content=INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES刚刚被科睿唯安（Clarivate Analytics）列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章，这意味着这些期刊的质量和学术诚信正在接受严格审查。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:56:27 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2228528, encodeId=f2d12228528f5, content=偏重的研究方向：药学 经验分享：这个杂志被ON HOLD了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9db08404890, createdName=ms9000001848883162, createdTime=Mon Sep 30 12:15:28 CST 2024, time=2024-09-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2222607, encodeId=4a2b222260e4f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿发邮件说接受了，但是网站上文章状态显示还是已提交修改怎么回事呀？等了快一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14e68366610, createdName=ms1000001977574257, createdTime=Tue Aug 27 09:03:57 CST 2024, time=2024-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220206, encodeId=841a222020637, content=见刊非常快，我是有这个编辑的邮箱，两周录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8857069, createdName=ms9000000801705910, createdTime=Thu Aug 15 10:02:57 CST 2024, time=2024-08-15, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2131249, encodeId=4121213124922, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：综合性期刊 经验分享：这个杂志非常安全，从未被预警过，本人发表了三篇，想咨询投稿后各个阶段状态和时间的可以咨询我，这个杂志的录用还是有些小窍门的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:42:12 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1196620, encodeId=4a841196620f8, content=您好，请教一下我每次提交文档都显示Invalid Captcha !!!，无法提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erqVLaq9Pf3WYPIXYjLw47yjVBxITzicTZ0q07rhKdyumOthJibQIJFdwKe3ibJ6K8TAFWfQT2YL4x2Q/132, createdBy=7cda2060778, createdName=earsmile, createdTime=Wed Feb 23 23:33:44 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122750, encodeId=16152122e507a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：色谱 经验分享：这个期刊带药物相关的，比较好录用，1个月能搞定，<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220712/73e5adb12e9542ba82e0cdedcb6f7d85/9147fd82fb334746850dda7ccd06a4c9.jpg, createdBy=fab48234685, createdName=小红帽起飞, createdTime=Thu Mar 30 15:04:38 CST 2023, time=2023-03-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214670, encodeId=3b1512146e0f9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉都没送出去审，半个月就给录用了，是增刊。需要付版面费，本来要2800欧，后来还价到1800欧，，，，相当水了，不过老板愿意付钱就好了，毕竟为了评奖学金不寒碜=-= , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=ms8000001934264310, createdTime=Tue Apr 26 18:14:17 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102586, encodeId=4b162102586f5, content=怎么回事，投稿几天后系统里面看不到自己的稿件状态了，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 25 12:29:10 CST 2022, time=2022-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2092855, encodeId=bdf4209285523, content=一直显示Invalid Captcha !!!，用过好多浏览器，都不行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71e38135633, createdName=ms6000000209127283, createdTime=Mon Oct 10 11:43:15 CST 2022, time=2022-10-10, status=1, ipAttribution=)]

2023-03-30 小红帽起飞来自广西

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：色谱
经验分享：这个期刊带药物相关的，比较好录用，1个月能搞定，#期刊论坛#

129 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233034, encodeId=d13d2233034dd, content=INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES刚刚被科睿唯安（Clarivate Analytics）列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章，这意味着这些期刊的质量和学术诚信正在接受严格审查。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:56:27 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2228528, encodeId=f2d12228528f5, content=偏重的研究方向：药学 经验分享：这个杂志被ON HOLD了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9db08404890, createdName=ms9000001848883162, createdTime=Mon Sep 30 12:15:28 CST 2024, time=2024-09-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2222607, encodeId=4a2b222260e4f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿发邮件说接受了，但是网站上文章状态显示还是已提交修改怎么回事呀？等了快一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14e68366610, createdName=ms1000001977574257, createdTime=Tue Aug 27 09:03:57 CST 2024, time=2024-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220206, encodeId=841a222020637, content=见刊非常快，我是有这个编辑的邮箱，两周录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8857069, createdName=ms9000000801705910, createdTime=Thu Aug 15 10:02:57 CST 2024, time=2024-08-15, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2131249, encodeId=4121213124922, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：综合性期刊 经验分享：这个杂志非常安全，从未被预警过，本人发表了三篇，想咨询投稿后各个阶段状态和时间的可以咨询我，这个杂志的录用还是有些小窍门的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:42:12 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1196620, encodeId=4a841196620f8, content=您好，请教一下我每次提交文档都显示Invalid Captcha !!!，无法提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erqVLaq9Pf3WYPIXYjLw47yjVBxITzicTZ0q07rhKdyumOthJibQIJFdwKe3ibJ6K8TAFWfQT2YL4x2Q/132, createdBy=7cda2060778, createdName=earsmile, createdTime=Wed Feb 23 23:33:44 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122750, encodeId=16152122e507a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：色谱 经验分享：这个期刊带药物相关的，比较好录用，1个月能搞定，<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220712/73e5adb12e9542ba82e0cdedcb6f7d85/9147fd82fb334746850dda7ccd06a4c9.jpg, createdBy=fab48234685, createdName=小红帽起飞, createdTime=Thu Mar 30 15:04:38 CST 2023, time=2023-03-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214670, encodeId=3b1512146e0f9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉都没送出去审，半个月就给录用了，是增刊。需要付版面费，本来要2800欧，后来还价到1800欧，，，，相当水了，不过老板愿意付钱就好了，毕竟为了评奖学金不寒碜=-= , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=ms8000001934264310, createdTime=Tue Apr 26 18:14:17 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102586, encodeId=4b162102586f5, content=怎么回事，投稿几天后系统里面看不到自己的稿件状态了，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 25 12:29:10 CST 2022, time=2022-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2092855, encodeId=bdf4209285523, content=一直显示Invalid Captcha !!!，用过好多浏览器，都不行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71e38135633, createdName=ms6000000209127283, createdTime=Mon Oct 10 11:43:15 CST 2022, time=2022-10-10, status=1, ipAttribution=)]

2022-04-26 ms8000001934264310

审稿速度:1.0 | 投稿命中率:95.0
经验分享：感觉都没送出去审，半个月就给录用了，是增刊。需要付版面费，本来要2800欧，后来还价到1800欧，，，，相当水了，不过老板愿意付钱就好了，毕竟为了评奖学金不寒碜=-=

93 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233034, encodeId=d13d2233034dd, content=INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES刚刚被科睿唯安（Clarivate Analytics）列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章，这意味着这些期刊的质量和学术诚信正在接受严格审查。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:56:27 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2228528, encodeId=f2d12228528f5, content=偏重的研究方向：药学 经验分享：这个杂志被ON HOLD了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9db08404890, createdName=ms9000001848883162, createdTime=Mon Sep 30 12:15:28 CST 2024, time=2024-09-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2222607, encodeId=4a2b222260e4f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿发邮件说接受了，但是网站上文章状态显示还是已提交修改怎么回事呀？等了快一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14e68366610, createdName=ms1000001977574257, createdTime=Tue Aug 27 09:03:57 CST 2024, time=2024-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220206, encodeId=841a222020637, content=见刊非常快，我是有这个编辑的邮箱，两周录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8857069, createdName=ms9000000801705910, createdTime=Thu Aug 15 10:02:57 CST 2024, time=2024-08-15, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2131249, encodeId=4121213124922, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：综合性期刊 经验分享：这个杂志非常安全，从未被预警过，本人发表了三篇，想咨询投稿后各个阶段状态和时间的可以咨询我，这个杂志的录用还是有些小窍门的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:42:12 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1196620, encodeId=4a841196620f8, content=您好，请教一下我每次提交文档都显示Invalid Captcha !!!，无法提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erqVLaq9Pf3WYPIXYjLw47yjVBxITzicTZ0q07rhKdyumOthJibQIJFdwKe3ibJ6K8TAFWfQT2YL4x2Q/132, createdBy=7cda2060778, createdName=earsmile, createdTime=Wed Feb 23 23:33:44 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122750, encodeId=16152122e507a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：色谱 经验分享：这个期刊带药物相关的，比较好录用，1个月能搞定，<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220712/73e5adb12e9542ba82e0cdedcb6f7d85/9147fd82fb334746850dda7ccd06a4c9.jpg, createdBy=fab48234685, createdName=小红帽起飞, createdTime=Thu Mar 30 15:04:38 CST 2023, time=2023-03-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214670, encodeId=3b1512146e0f9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉都没送出去审，半个月就给录用了，是增刊。需要付版面费，本来要2800欧，后来还价到1800欧，，，，相当水了，不过老板愿意付钱就好了，毕竟为了评奖学金不寒碜=-= , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=ms8000001934264310, createdTime=Tue Apr 26 18:14:17 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102586, encodeId=4b162102586f5, content=怎么回事，投稿几天后系统里面看不到自己的稿件状态了，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 25 12:29:10 CST 2022, time=2022-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2092855, encodeId=bdf4209285523, content=一直显示Invalid Captcha !!!，用过好多浏览器，都不行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71e38135633, createdName=ms6000000209127283, createdTime=Mon Oct 10 11:43:15 CST 2022, time=2022-10-10, status=1, ipAttribution=)]

2022-11-25 1463b3a1m11暂无昵称来自浙江省

怎么回事，投稿几天后系统里面看不到自己的稿件状态了，绝了

87 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233034, encodeId=d13d2233034dd, content=INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES刚刚被科睿唯安（Clarivate Analytics）列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章，这意味着这些期刊的质量和学术诚信正在接受严格审查。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:56:27 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2228528, encodeId=f2d12228528f5, content=偏重的研究方向：药学 经验分享：这个杂志被ON HOLD了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9db08404890, createdName=ms9000001848883162, createdTime=Mon Sep 30 12:15:28 CST 2024, time=2024-09-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2222607, encodeId=4a2b222260e4f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿发邮件说接受了，但是网站上文章状态显示还是已提交修改怎么回事呀？等了快一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14e68366610, createdName=ms1000001977574257, createdTime=Tue Aug 27 09:03:57 CST 2024, time=2024-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2220206, encodeId=841a222020637, content=见刊非常快，我是有这个编辑的邮箱，两周录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ba8857069, createdName=ms9000000801705910, createdTime=Thu Aug 15 10:02:57 CST 2024, time=2024-08-15, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2131249, encodeId=4121213124922, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：综合性期刊 经验分享：这个杂志非常安全，从未被预警过，本人发表了三篇，想咨询投稿后各个阶段状态和时间的可以咨询我，这个杂志的录用还是有些小窍门的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:42:12 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1196620, encodeId=4a841196620f8, content=您好，请教一下我每次提交文档都显示Invalid Captcha !!!，无法提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erqVLaq9Pf3WYPIXYjLw47yjVBxITzicTZ0q07rhKdyumOthJibQIJFdwKe3ibJ6K8TAFWfQT2YL4x2Q/132, createdBy=7cda2060778, createdName=earsmile, createdTime=Wed Feb 23 23:33:44 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122750, encodeId=16152122e507a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：色谱 经验分享：这个期刊带药物相关的，比较好录用，1个月能搞定，<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220712/73e5adb12e9542ba82e0cdedcb6f7d85/9147fd82fb334746850dda7ccd06a4c9.jpg, createdBy=fab48234685, createdName=小红帽起飞, createdTime=Thu Mar 30 15:04:38 CST 2023, time=2023-03-30, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214670, encodeId=3b1512146e0f9, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉都没送出去审，半个月就给录用了，是增刊。需要付版面费，本来要2800欧，后来还价到1800欧，，，，相当水了，不过老板愿意付钱就好了，毕竟为了评奖学金不寒碜=-= , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220808/057d6ce5c7204a51be4c641b39cfb5af/f12cfe8ccc88443197fca9ea84a00455.jpg, createdBy=0bad5338455, createdName=ms8000001934264310, createdTime=Tue Apr 26 18:14:17 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102586, encodeId=4b162102586f5, content=怎么回事，投稿几天后系统里面看不到自己的稿件状态了，绝了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Fri Nov 25 12:29:10 CST 2022, time=2022-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2092855, encodeId=bdf4209285523, content=一直显示Invalid Captcha !!!，用过好多浏览器，都不行。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71e38135633, createdName=ms6000000209127283, createdTime=Mon Oct 10 11:43:15 CST 2022, time=2022-10-10, status=1, ipAttribution=)]

2022-10-10 ms6000000209127283

一直显示Invalid Captcha !!!，用过好多浏览器，都不行。

97 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务